Insider Transactions

UNITEDHEALTH GROUP INC (UNH) Insider Transactions

Over the last 12 months, 18 UNITEDHEALTH GROUP INC (UNH) insiders filed 140 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $293.6K in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 140 (1-year window)

Each row is a single Form 4 filing event for UNH, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-06-05 Conway Patrick Hugh Chief Executive Officer, Optum Other F $274.4K 687 $399.47
2026-06-03 Zaetta Christopher R EVP & Chief Legal Officer Other F $50.5K 134 $377.00
2026-06-02 Conway Patrick Hugh Chief Executive Officer, Optum Other F $77.0K 204 $377.92
2026-04-23 Conway Patrick Hugh Chief Executive Officer, Optum Sell S $284.0K 800 $355.00
2026-04-01 HOOPER MICHELE J Grant A $0 206 $0.00
2026-04-01 MCNABB FREDERICK WILLIAM III Grant A $0 388 $0.00
2026-04-01 Baker Charles D. Grant A $0 343 $0.00
2026-04-01 Gil Kristen Grant A $0 320 $0.00
2026-04-01 Noseworthy John H Grant A $0 320 $0.00
2026-04-01 GARCIA PAUL R Grant A $0 206 $0.00
2026-04-01 GARCIA PAUL R Grant A $0 137 $0.00
2026-04-01 Gottlieb Scott Grant A $0 320 $0.00
2026-04-01 MONTGOMERY RICE VALERIE MD Grant A $0 343 $0.00
2026-04-01 FLYNN TIMOTHY PATRICK Grant A $0 350 $0.00
2026-03-17 MONTGOMERY RICE VALERIE MD Grant $0 53 $0.00
2026-03-17 DeVeydt Wayne S Chief Financial Officer Grant $0 150 $0.00
2026-03-17 Stankiewicz Dennis Andrew Chief Accounting Officer Grant $0 68 $0.00
2026-03-17 GARCIA PAUL R Grant $0 16 $0.00
2026-03-17 Noseworthy John H Grant $0 52 $0.00
2026-03-17 Zaetta Christopher R EVP & Chief Legal Officer Grant $0 90 $0.00
2026-03-17 Noel Timothy John Chief Executive Officer, UHC Grant $0 102 $0.00
2026-03-17 MCNABB FREDERICK WILLIAM III Grant $0 64 $0.00
2026-03-17 FLYNN TIMOTHY PATRICK Grant $0 79 $0.00
2026-03-17 HEMSLEY STEPHEN J CEO, UHG Grant $0 61 $0.00
2026-03-17 Baker Charles D. Grant $0 14 $0.00
2026-03-17 McSweeney Erin EVP & Chief People Officer Grant $0 65 $0.00
2026-03-17 HOOPER MICHELE J Grant $0 292 $0.00
2026-03-17 Gil Kristen Grant $0 8 $0.00
2026-03-17 Gottlieb Scott Grant $0 1 $0.00
2026-03-17 Conway Patrick Hugh Chief Executive Officer, Optum Grant $0 125 $0.00
2026-02-23 ROOS THOMAS E Chief Accounting Officer Grant $42.9K 152 $282.34
2026-02-23 ROOS THOMAS E Chief Accounting Officer Grant $0 2,436 $0.00
2026-02-23 ROOS THOMAS E Chief Accounting Officer Grant $0 9,768 $0.00
2026-02-23 Zaetta Christopher R EVP & Chief Legal Officer Grant $36.6K 129 $282.34
2026-02-23 Zaetta Christopher R EVP & Chief Legal Officer Grant $0 7,084 $0.00
2026-02-23 Zaetta Christopher R EVP & Chief Legal Officer Grant $0 28,414 $0.00
2026-02-23 Noel Timothy John Chief Executive Officer, UHC Grant $34.8K 123 $282.34
2026-02-23 Noel Timothy John Chief Executive Officer, UHC Grant $0 8,855 $0.00
2026-02-23 Noel Timothy John Chief Executive Officer, UHC Grant $0 35,517 $0.00
2026-02-23 McSweeney Erin EVP & Chief People Officer Grant $36.9K 131 $282.34
2026-02-23 McSweeney Erin EVP & Chief People Officer Grant $0 4,871 $0.00
2026-02-23 McSweeney Erin EVP & Chief People Officer Grant $0 19,535 $0.00
2026-02-23 Conway Patrick Hugh Chief Executive Officer, Optum Grant $50.5K 179 $282.34
2026-02-23 Conway Patrick Hugh Chief Executive Officer, Optum Grant $0 8,855 $0.00
2026-02-23 Conway Patrick Hugh Chief Executive Officer, Optum Grant $0 35,517 $0.00
2026-02-23 DeVeydt Wayne S Chief Financial Officer Grant $2.5M 8,855 $282.34
2026-02-23 DeVeydt Wayne S Chief Financial Officer Grant $0 35,517 $0.00
2026-02-20 McSweeney Erin EVP & Chief People Officer Grant $39.6K 137 $290.00
2026-02-20 McSweeney Erin EVP & Chief People Officer Grant $45.0K 155 $290.00
2026-02-20 Zaetta Christopher R EVP & Chief Legal Officer Grant $37.9K 131 $290.00

Showing the most recent 50 of 140 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track UNH Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for UNITEDHEALTH GROUP INC?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of UNITEDHEALTH GROUP INC (UNH) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of UNITEDHEALTH GROUP INC (UNH) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.